Navigation Links
Study Shows Otamixaban Substantially Reduced Complications of Invasive Management of Acute Coronary Syndromes
Date:8/30/2009

I SEPIA-ACS1/ TIMI-42 study randomized 3241 patients from 36 countries in 6 treatment arms. The study assessed the efficacy and safety of five different doses of otamixaban versus the standard unfractionated heparin plus Glycoprotein IIb/IIIa inhibitor (eptifibatide), on background of standard dual antiplatelet therapy, in patients with high-risk non-ST-elevation acute coronary syndromes. SEPIA-ACS1 study showed that otamixaban displayed clinically meaningful activity on the primary endpoint from the threshold dose of 0.070 mg/kg/h, the second tested dose, with a consistent antithrombotic effect up to the 5th highest tested dosage. The lowest studied dosage was prematurely stopped due to insufficient activity, based on recommendation by an independent data monitoring board. Moreover a combined analysis of the intermediate doses (0.105 and 0.140 mg/kg/h) of otamixaban arms showed that otamixaban reduced by approximately 46 percent (p=0.0198) the risk of the composite of death or a second myocardial infarction, a predefined study secondary efficacy endpoint.

The potent antithrombotic effect of otamixaban was also accompanied with a dose-dependent bleeding profile. Combined intermediate otamixaban dosages showed a safety profile not statistically different with regard to TIMI major or minor bleeding through 7 days, in comparison to UFH and GPIIb/IIIa inhibitor comparator (RR 1.20, 95% CI 0.64-2.27, p=0.5634).

"The SEPIA-ACS1 trial is providing very encouraging results for a new and more effective treatment approach," said Marc Cluzel, MD Senior Vice President Research and Development Sanofi-aventis. "We aim, on the basis of these findings to address through our development program remaining patients', practionners' and payers' needs for management of ACS."

Acute Coronary Syndromes is a general term used to regroup clinical symptoms related to acute myocardial ischemia. ACS represents an area of important
'/>"/>

SOURCE Sanofi-aventis
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. New Large-Scale, Global Study Provides Additional Information About an Intensified Dose-Regimen of PLAVIX(R) in Acute Coronary Syndrome Patients Undergoing Angioplasty
2. Gen-Probe Begins U.S. Clinical Study of PROGENSA(R) PCA3 Assay, New Molecular Test to Help Assess Prostate Cancer Risk
3. Lurasidone Demonstrated Efficacy in Treating Patients With Schizophrenia in Pivotal Phase 3 Study
4. Cardium Completes Initial Patient Evaluation Period for MATRIX Phase 2b Excellarate Clinical Study
5. CardioDx Completes Validation Study of First-Of-Its-Kind Genomic Test for Coronary Artery Disease
6. R-Tech Ueno Completes Subject Enrollment in Phase 2 Clinical Study of 0.15% UF-021
7. WorldHeart Receives US Clinical Study Approval for the Levacor(TM) VAD
8. Impax Pharmaceuticals Selects OmniComm Systems to Provide eClinical Solutions for International Phase III Study in Parkinsons Disease
9. Study Links Fetal Fibronectin Testing with Changes in Management Decisions for Symptomatic and Asymptomatic Women at Risk for Preterm Birth
10. Study of Lacrisert(R) Dry Eye Insert Published in The Ocular Surface
11. Amarex Clinical Research Selects OmniComm Systems to Provide eClinical Solutions for Phase III Medical Device Study and Joins OmniComms CRO Preferred Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... 30, 2014 Research and Markets has announced ... Forecasts to 2019" report to their offering. ... to grow at a lower CAGR in developed countries; however, it ... China , India , and ... The growth of the hematology analyzers and reagents market is ...
(Date:7/30/2014)... July 30, 2014 Reportlinker.com announces that ... its catalogue: mHealth and Home Monitoring ... Executive summary mHealth ... to better outcomes, decreased costs and improved sustainability ... solutions is still in an early stage, but ...
(Date:7/30/2014)... Germany , July 30, 2014  invendo ... and computer-assisted ("robotic") colonoscopy system, today announced the appointment ... medical device executive, as a new member of its ... highly respected global visionary in the medical device industry. ... and Chief Executive Officer at Given Imaging Ltd. (NASDAQ/TASE: ...
Breaking Medicine Technology:Hematology Analyzers & Reagents Market - Forecasts to 2019 2mHealth and Home Monitoring - 6th Edition 2mHealth and Home Monitoring - 6th Edition 3mHealth and Home Monitoring - 6th Edition 4mHealth and Home Monitoring - 6th Edition 5mHealth and Home Monitoring - 6th Edition 6mHealth and Home Monitoring - 6th Edition 7mHealth and Home Monitoring - 6th Edition 8mHealth and Home Monitoring - 6th Edition 9mHealth and Home Monitoring - 6th Edition 10mHealth and Home Monitoring - 6th Edition 11invendo medical Appoints Nachum (Homi) Shamir To The Company's Board Of Directors 2invendo medical Appoints Nachum (Homi) Shamir To The Company's Board Of Directors 3
... 2012  Common practices for changing from one opioid to another, ... to the growing number of opioid-related fatalities, new research suggests. ... study using this new model of opioid rotation are presented ... official journal of the American Academy of Pain Medicine (AAPM). ...
...  Aided by the launch of Rx-to-OTC switch brand Allegra (Sanofi-Aventis) ... 16.3% in 2011 to become the fastest growing category on ... Drugs USA 2011 report by international consulting and research ... market posted a gain of 2.4% reaching $21.4 billion in 2011 ...
Cached Medicine Technology:Research Finds Overdose Deaths Occur When Changing Opioids 2Research Finds Overdose Deaths Occur When Changing Opioids 3Strong Rx-to-OTC Switch Performance and Holistic Marketing Drive Solid OTC Drug Market Growth in 2011, According to Kline 2Strong Rx-to-OTC Switch Performance and Holistic Marketing Drive Solid OTC Drug Market Growth in 2011, According to Kline 3
(Date:7/30/2014)... 2014 Good Neighbor Community Services ... upcoming episode of Innovations with Ed Begley Jr, ... and show times TBA. , In this segment, ... Services’ vision to redefine the traditional approach to ... services. Through passion, innovation, determination, excellence, and collaboration, ...
(Date:7/30/2014)... CA (PRWEB) July 30, 2014 SF ... accessories at the lowest prices on the internet with ... Cables in two lengths and two colors. These lightning ... standards. , The high quality SF Cable ... connector with digital signal delivering faster charging and syncing. ...
(Date:7/30/2014)... July 30, 2014 Hamilton Facial ... of its new Carmel office on July 30th. After ... finally be moving to the state-of-the-art suite, located only ... innovative space will allow for one-on-one patient comfort, shorter ... experience. , Dr. Hamilton’s new office-suite will continue ...
(Date:7/30/2014)... ... ... ... , UCLA ... For the study, published this week in the peer-reviewed journal Quality of Life Research , a UCLA team led by Dr. ...
(Date:7/30/2014)... 2014 As the controversy surrounding the ... surgeries continues to grow, Bernstein Liebhard LLP notes that ... for a ban on uterine morcellation. According to a ... with leiomyosarcoma following a hysterectomy that involved the use ... diagnosis, the aggressive cancer had progressed to Stage 4. ...
Breaking Medicine News(10 mins):Health News:Good Neighbor Community Services to be Featured in an Upcoming Episode of Innovations With Ed Begley, Jr. 2Health News:SF Cable Delivers Certified Lightning Cable in Multiple Sizes and Colors 2Health News:Hamilton Facial Plastic Surgery Opens New Carmel Office 2Health News:Diverticulitis patients reveal psychological, physical symptoms long after acute attacks 2Health News:Diverticulitis patients reveal psychological, physical symptoms long after acute attacks 3Health News:Power Morcellator Controversy Grows, as Bernstein Liebhard LLP Notes Another Call to Ban Uterine Morcellation 2Health News:Power Morcellator Controversy Grows, as Bernstein Liebhard LLP Notes Another Call to Ban Uterine Morcellation 3Health News:Power Morcellator Controversy Grows, as Bernstein Liebhard LLP Notes Another Call to Ban Uterine Morcellation 4
... put in their,current Medicare prescription drug plans, the ... monthly premiums for 2008, says new analysis,released by ... and its proprietary DataFrame(R),database, Avalere experts computed an ... marketplace. Under this method, the premiums of,plans with ...
... Denying Right, to Fly; Case Could Set Precedent for Airline Travel Rights ... ... Oct. 5 A 26-year-old disabled man,who was denied access to a ... Andy Gates is affected by dystonia, an obscure neuromuscular movement,disorder that causes ...
... two,studies comparing colorectal cancer screening by conventional or ... sparked interest in colorectal cancer screening and may ... one a large multi-center,trial sponsored by the NIH ... of Wisconsin published in the New England Journal ...
... good for the heart, researchers say , , FRIDAY, Oct. 5 ... according to a study ranking eight popular weight-loss programs. , ... better than those with a heavy protein focus. , The ... potential to prevent heart disease risk factors. The Atkins diet ...
... to Acquire Groundbreaking Tool, AUSTIN, Texas, Oct. 5 ... a new robotic surgery system that allows for,minimally invasive ... a,stroke. Called the Sensei(TM) Robotic Catheter System and Artisan(TM),Control ... be installed in,the country after the Cleveland Clinic. ...
... support,service provider Healthways is opening its first service ... Nashville, Tennessee,will employ 100 workers in the short-term ... the medium term. "Healthways, decision to open ... success for both the town and the state ...
Cached Medicine News:Health News:Average Medicare Prescription Drug Premiums to Rise 21% 2Health News:Major US Airline Discriminates Against Disabled Passenger, Lawsuit Charges 2Health News:Frequently Asked Questions When Considering a Colorectal Cancer Screening Test, From the American College of Gastroenterology 2Health News:Frequently Asked Questions When Considering a Colorectal Cancer Screening Test, From the American College of Gastroenterology 3Health News:Study Rates Heart Health of Popular Diet Plans 2Health News:Study Rates Heart Health of Popular Diet Plans 3Health News:Study Rates Heart Health of Popular Diet Plans 4Health News:St. David's Medical Center Implements New Robotic Technology to Treat Common Heart Rhythm Disorders 2Health News:St. David's Medical Center Implements New Robotic Technology to Treat Common Heart Rhythm Disorders 3Health News:Healthways Enters German Healthcare Market 2
... several different two-stage, oil-sealed, rotary vane vacuum ... applications. Each pump comes complete with a ... and Oil Mist Filter (EMF-10). The GBORK ... ballast to keep the oil clean without ...
... is perfect for electrophoresis gel drying, and ... of greater than 29 inches of mercury ... with the Model 583 gel dryer. Includes: ... and 3/8 inch ID vacuum tubing, vacuum ...
Variable Speed Pump...
Inquire...
Medicine Products: